Synapse - Works

Results (4808)

An open-label phase II study of buparlisib (BKM120) in patients with relapsed and refractory diffuse large B-Cell lymphoma (DLBCL), mantle cell lymphoma (MCL) and follicular lymphoma (FL)

Meeting Abstract

Younes, A.; Salles, G.; Martinelli, G.; Bociek, R. G.; Barrigon, D. C.; Barca, E. G.; Turgut, M.; Gerecitano, J. F.; Herbst, F.; Williams, L.; more...
Blood (2015)

Fulltext@MSK | Save

Idelalisib plus bendamustine and rituximab (BR) is superior to BR alone in patients with relapsed/refractory chronic lymphocytic leukemia: Results of a phase 3 randomized double-blind placebo-controlled study

Meeting Abstract

Zelenetz, A. D.; Robak, T.; Coiffier, B.; Delgado, J.; Marlton, P.; Adewoye, A. H.; Kim, Y.; Dreiling, L. K.; Hillmen, P.
Blood (2015)

Fulltext@MSK | Save

The clonal architecture of CXCR4 mutations in Waldenstrom's Macroglobulinemia shows highly variable subclonal distribution, and multiple mutations within individual patients indicative of targeted genomic instability

Meeting Abstract

Xu, L.; Hunter, Z.; Tsakmaklis, N.; Cao, Y.; Yang, G.; Chen, J.; Liu, X.; Kanan, S.; Castillo, J. J.; Tai, Y. T.; more...
Blood (2015)

Fulltext@MSK | Save

Preclinical efficacy of TGF-beta receptor I kinase inhibitor, galunisertib, in myelofibrosis

Meeting Abstract

Yue, L.; Bartenstein, M.; Zhao, W.; Ho, W. T.; Zhang, L.; Rapaport, F.; Levine, R. L.; Zhao, Z. J.; Verma, A.; Epling-Burnette, P. K.
Blood (2015)

Fulltext@MSK | Save

Expression of an oncogenic ERG isoform characterizes a distinct subtype of B-progenitor acute lymphoblastic leukemia

Meeting Abstract

Zhang, J. H.; McCastlain, K.; Qu, C. X.; Wu, G.; Edmonson, M.; Li, Y. J.; Wei, L.; Payne-Turner, D.; Yoshihara, H.; Churchman, M. L.; more...
Blood (2015)

Fulltext@MSK | Save

Phase 1 trial testing single agent CUDC-907, a novel, oral dual inhibitor of histone deacetylase (HDAC) and PI3K: Initial assessment of patients with relapsed or refractory (RR) diffuse large B-Cell lymphoma (DLBCL), including double expressor (DE) lymphoma

Meeting Abstract

Younes, A.; Berdeja, J. G.; Patel, M. R.; Kelly, K. R.; Flinn, I. W.; Gerecitano, J. F.; Neelapu, S. S.; Copeland, A. R.; Akins, A.; Clancy, M.; more...
Blood (2015)

Fulltext@MSK | Save

Outcomes in diffuse large B-cell lymphoma (DLBCL) patients relapsing after autologous stem cell transplantation (ASCT): An analysis of patients included in the CORAL study

Meeting Abstract

Van Den Neste, E.; Schmitz, N.; Mounier, N.; Gill, D.; Trneny, M.; Milpied, N.; Radford, J. A.; Ketterer, N.; Shpilberg, O.; Duhrsen, U.; more...
Blood (2015)

Fulltext@MSK | Save

Initial results of US intergroup trial of response-adapted chemotherapy or chemotherapy/radiation therapy based on PET for non-bulky stage I and II Hodgkin lymphoma (HL) (CALGB/Alliance 50604)

Meeting Abstract

Straus, D. J.; Pitcher, B.; Kostakoglu, L.; Grecula, J. C.; Hsi, E. D.; Schoder, H.; Jung, S. H.; Popplewell, L. L.; Chang, J. E.; Moskowitz, C. H.; more...
Blood (2015)

Fulltext@MSK | Save

Preliminary results from a phase 1/2, open-label, dose-escalation clinical trial of IMO-8400 in patients with relapsed or refractory Waldenstrom's macroglobulinemia

Meeting Abstract

Thomas, S. K.; Harb, W. A.; Beck, J. T.; Nashat, G.; Palomba, M. L.; Ansell, S. M.; Eradat, H.; Libby, E. N.; Advani, R. H.; Hajdenberg, J.; more...
Blood (2015)

Fulltext@MSK | Save

A clinicogenetic risk model (m7-FLIPI) prospectively identifies one-half of patients with early disease progression of follicular lymphoma after first-line immunochemotherapy

Meeting Abstract

Vindi, J.; Kridel, R.; Staiger, A. M.; Szczepanowski, M.; Horn, H.; Dreyling, M. H.; Rosenwald, A.; Ott, G.; Klapper, W.; Zelenetz, A. D.; more...
Blood (2015)

Fulltext@MSK | Save